Gastroenterology Research and Practice / 2018 / Article / Tab 1

Research Article

The Interaction of lncRNA-HEIH and lncRNA-HULC with HBXIP in Hepatitis B Patients

Table 1

Clinical features of patients.

ParameterControlHBVHBV + HCHBV + HCC

Gender
 Female13141210>0.05
 Male12111315
HBsAg
 Negative25000<0.05
 Positive0252525
Age45.07 ± 15.0640.18 ± 16.2542.31 ± 8.5645.62 ± 11.28>0.05
ALP (U/L)55.58 ± 12.0191.46 ± 12.96121.77 ± 16.89157.29 ± 21.78<0.05
ALB (g/L)48.44 ± 8.8843.32 ± 7.5828.21 ± 6.6930.37 ± 6.84<0.05
TBIL (μmol/L)15.23 ± 3.6722.24 ± 4.5233.52 ± 7.1740.44 ± 8.03<0.05
DBIL (μmol/L)4.28 ± 1.138.44 ± 1.6117.22 ± 3.3527.24 ± 5.98<0.05
AFP (μg/L)4.95 ± 1.1326.83 ± 4.6752.79 ± 7.76122.74 ± 18.76<0.05
ALT (U/L)25.48 ± 6.68181.67 ± 21.9069.28 ± 11.1178.24 ± 10.94<0.05
AST (U/L)22.14 ± 5.11196.75 ± 20.2989.89 ± 13.22102.25 ± 14.11<0.05
HBV-DNA (copies/mL)0(7.12 ± 0.28) × 105(2.23 ± 0.47) × 104(7.35 ± 0.55) × 104<0.05

HBsAg: hepatitis B surface antigen; ALP: alkaline phosphatase; ALB: albumin; TBIl: total bilirubin; DBIl: direct bilirubin; AFP: alpha-fetoprotein; ALT: alanine aminotransferase; AST: aspartate aminotransferase.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.